Your browser doesn't support javascript.
loading
Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma.
Lee, Jimmy; Zhang, Liang Leo; Wu, Wenjun; Guo, Hui; Li, Yan; Sukhanova, Madina; Venkataraman, Girish; Huang, Shengjian; Zhang, Hui; Alikhan, Mir; Lu, Pin; Guo, Ailin; Galanina, Natalie; Andrade, Jorge; Wang, Michael L; Wang, Y Lynn.
Afiliação
  • Lee J; Lymphoma Translational Pathology, Department of Pathology, University of Chicago, Chicago, IL.
  • Zhang LL; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wu W; Lymphoma Translational Pathology, Department of Pathology, University of Chicago, Chicago, IL.
  • Guo H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Li Y; Center for Research Informatics and.
  • Sukhanova M; Department of Pediatrics, University of Chicago, Chicago, IL.
  • Venkataraman G; Lymphoma Translational Pathology, Department of Pathology, University of Chicago, Chicago, IL.
  • Zhang H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Alikhan M; Department of Pathology, NorthShore University HealthSystem, Evanston, IL; and.
  • Lu P; Lymphoma Translational Pathology, Department of Pathology, University of Chicago, Chicago, IL.
  • Guo A; Lymphoma Translational Pathology, Department of Pathology, University of Chicago, Chicago, IL.
  • Galanina N; Department of Medicine, University of California, San Diego, CA.
  • Andrade J; Center for Research Informatics and.
  • Wang ML; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wang YL; Lymphoma Translational Pathology, Department of Pathology, University of Chicago, Chicago, IL.
Blood Adv ; 2(16): 2039-2051, 2018 08 28.
Article em En | MEDLINE | ID: mdl-30115641

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Proteínas Proto-Oncogênicas c-myc / Proteínas de Choque Térmico HSP90 / Resistencia a Medicamentos Antineoplásicos / Linfoma de Célula do Manto Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Proteínas Proto-Oncogênicas c-myc / Proteínas de Choque Térmico HSP90 / Resistencia a Medicamentos Antineoplásicos / Linfoma de Célula do Manto Idioma: En Ano de publicação: 2018 Tipo de documento: Article